Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage

scientific article

Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.02428-14
P932PMC publication ID4068522
P698PubMed publication ID24752265

P50authorLaurent PoirelQ57551509
Patrice NordmannQ63214194
Johann D D PitoutQ87674893
P2093author name stringGisele Peirano
Akke K van der Bij
Veronika L Tchesnokova
Michael Costello
Joshua L Freeman
P2860cites workEstablishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standardQ24522329
Extended-spectrum beta-lactamases: a clinical updateQ24534999
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typingQ29614699
The CTX-M beta-lactamase pandemic.Q30356558
Rapid and simple determination of the Escherichia coli phylogenetic groupQ33919655
Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England.Q34057927
qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United StatesQ34973794
Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, NetherlandsQ35065929
Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzymeQ35127937
Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian regionQ35689028
Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolatesQ35758933
Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010)Q36086484
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from JapanQ36538723
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coliQ36607290
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concernQ37091253
Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veteransQ37220795
Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infectionsQ37247785
Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004Q37247793
Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.Q37264353
The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-RxQ37408471
Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypesQ37534226
Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.Q37671098
Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.Q37713679
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009.Q40028752
Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.Q42111230
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from CanadaQ42111425
Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010.Q42872176
Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitalsQ43111830
The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms.Q43955125
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.Q46852401
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strainsQ47714144
Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from Rio de Janeiro, Brazil.Q54358049
Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa.Q54365603
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectEscherichia coliQ25419
P304page(s)3762-3767
P577publication date2014-04-21
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleCharacteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage
P478volume58

Reverse relations

cites work (P2860)
Q36887866Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
Q28067176Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on β-lactams and polymyxins
Q35607916Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice.
Q41480033CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic
Q30395087Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and Japan
Q53704735Comprehensive Molecular Characterization of Escherichia coli Isolates from Urine Samples of Hospitalized Patients in Rio de Janeiro, Brazil.
Q40190138Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009.
Q26749590Escherichia coli β-Lactamases: What Really Matters
Q57930070Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
Q90645279Extensive Genetic Commonality among Wildlife, Wastewater, Community, and Nosocomial Isolates of Escherichia coli Sequence Type 131 (H30R1 and H30Rx Subclones) That Carry blaCTX-M-27 or blaCTX-M-15
Q26752573Fluoroquinolone-Resistant Enteric Bacteria in Sub-Saharan Africa: Clones, Implications and Research Needs
Q37023267Genetic Features of MCR-1-Producing Colistin-Resistant Escherichia coli Isolates in South Africa
Q56952615Genetic relatedness of Staphylococcus aureus isolates obtained from cystic fibrosis patients at a tertiary academic hospital in Pretoria, South Africa
Q40171775Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-H30Rx and ST131-H30R1 Strains
Q28112087Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene
Q90218796Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents
Q91713655High Prevalence of ST131 Subclades C2-H30Rx and C1-M27 Among Extended-Spectrum β-Lactamase-Producing Escherichia coli Causing Human Extraintestinal Infections in Patients From Two Hospitals of Spain and France During 2015
Q35843094High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
Q40239533High-Resolution Melting Analysis for Rapid Detection of Sequence Type 131 Escherichia coli
Q41220729Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli
Q37120155Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans
Q38922047Longitudinal genomic surveillance of multidrug-resistant Escherichia coli carriage in a long-term care facility in the United Kingdom
Q53699618Molecular Epidemiology of Staphylococcus epidermidis Implicated in Catheter-Related Bloodstream Infections at an Academic Hospital in Pretoria, South Africa.
Q35647555Molecular characteristics of extended-spectrum cephalosporin-resistant Enterobacteriaceae from humans in the community
Q40959363Molecular characterization of bacteremic Escherichia coli isolates in Romania
Q30240591Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries.
Q30397339Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance
Q47123962Prevalence and characteristics of ST131 clone among unselected clinical Escherichia coli in a Chinese university hospital
Q37334691Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia
Q92404356Sequence Types, Clonotypes, Serotypes, and Virotypes of Extended-Spectrum β-Lactamase-Producing Escherichia coli Causing Bacteraemia in a Spanish Hospital Over a 12-Year Period (2000 to 2011)
Q58694590Systematic review in South Africa reveals antibiotic resistance genes shared between clinical and environmental settings
Q30393531Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics
Q30386217The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts.
Q33806382The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011-2012).
Q30300020The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae
Q90050491Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach
Q47104393Virulence genes and subclone status as markers of experimental virulence in a murine sepsis model among Escherichia coli sequence type 131 clinical isolates from Spain.